Medtronic Current Ratio 2010-2024 | MDT
Medtronic Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2024-07-31 | $21.95B | $10.29B | 2.13 |
2024-04-30 | $21.94B | $10.79B | 2.03 |
2024-01-31 | $22.51B | $9.79B | 2.30 |
2023-10-31 | $22.08B | $9.66B | 2.29 |
2023-07-31 | $21.87B | $9.05B | 2.42 |
2023-04-30 | $21.68B | $9.05B | 2.40 |
2023-01-31 | $25.36B | $14.42B | 1.76 |
2022-10-31 | $25.40B | $14.47B | 1.76 |
2022-07-31 | $22.14B | $14.05B | 1.58 |
2022-04-30 | $23.06B | $12.39B | 1.86 |
2022-01-31 | $23.30B | $8.93B | 2.61 |
2021-10-31 | $22.73B | $7.80B | 2.91 |
2021-07-31 | $22.43B | $7.76B | 2.89 |
2021-04-30 | $22.55B | $8.51B | 2.65 |
2021-01-31 | $26.35B | $12.53B | 2.10 |
2020-10-31 | $26.04B | $12.07B | 2.16 |
2020-07-31 | $24.51B | $13.09B | 1.87 |
2020-04-30 | $22.03B | $10.37B | 2.13 |
2020-01-31 | $24.04B | $8.74B | 2.75 |
2019-10-31 | $22.65B | $8.17B | 2.77 |
2019-07-31 | $22.71B | $8.52B | 2.67 |
2019-04-30 | $21.97B | $8.47B | 2.59 |
2019-01-31 | $20.88B | $8.85B | 2.36 |
2018-10-31 | $21.65B | $8.46B | 2.56 |
2018-07-31 | $22.46B | $9.11B | 2.47 |
2018-04-30 | $22.98B | $10.08B | 2.28 |
2018-01-31 | $26.61B | $10.93B | 2.43 |
2017-10-31 | $25.16B | $10.50B | 2.40 |
2017-07-31 | $24.78B | $15.15B | 1.64 |
2017-04-30 | $24.87B | $14.26B | 1.74 |
2017-01-31 | $22.42B | $12.67B | 1.77 |
2016-10-31 | $22.53B | $9.60B | 2.35 |
2016-07-31 | $23.50B | $7.90B | 2.98 |
2016-04-30 | $23.60B | $7.17B | 3.29 |
2016-01-31 | $27.57B | $8.14B | 3.39 |
2015-10-31 | $28.72B | $8.13B | 3.54 |
2015-07-31 | $29.15B | $7.66B | 3.81 |
2015-04-30 | $30.84B | $9.17B | 3.36 |
2015-01-31 | $38.16B | $5.61B | 6.80 |
2014-10-31 | $21.60B | $6.95B | 3.11 |
2014-07-31 | $20.77B | $5.43B | 3.82 |
2014-04-30 | $21.21B | $5.56B | 3.82 |
2014-01-31 | $20.39B | $5.63B | 3.62 |
2013-10-31 | $19.48B | $5.50B | 3.55 |
2013-07-31 | $18.09B | $4.29B | 4.22 |
2013-04-30 | $17.85B | $3.95B | 4.52 |
2013-01-31 | $9.16B | $6.96B | 1.32 |
2012-10-31 | $9.44B | $6.62B | 1.43 |
2012-07-31 | $9.18B | $5.81B | 1.58 |
2012-04-30 | $16.34B | $5.93B | 2.76 |
2012-01-31 | $9.31B | $4.56B | 2.04 |
2011-10-31 | $9.01B | $4.73B | 1.90 |
2011-07-31 | $9.29B | $4.81B | 1.93 |
2011-04-30 | $9.15B | $4.73B | 1.94 |
2011-01-31 | $9.99B | $6.41B | 1.56 |
2010-10-31 | $9.89B | $5.90B | 1.68 |
2010-07-31 | $10.00B | $5.61B | 1.78 |
2010-04-30 | $9.84B | $5.12B | 1.92 |
2010-01-31 | $7.98B | $3.79B | 2.10 |
2009-10-31 | $7.31B | $3.28B | 2.23 |
2009-07-31 | $7.28B | $3.13B | 2.33 |
2009-04-30 | $7.45B | $3.15B | 2.37 |
2009-01-31 | $7.21B | $3.17B | 2.28 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $114.719B | $32.364B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.139B | 25.33 |
Stryker (SYK) | United States | $137.702B | 32.18 |
Boston Scientific (BSX) | United States | $122.346B | 37.26 |
EssilorLuxottica (ESLOY) | France | $106.985B | 0.00 |
Haleon (HLN) | United Kingdom | $48.286B | 35.30 |
Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
ResMed (RMD) | United States | $35.640B | 31.38 |
Koninklijke Philips (PHG) | Netherlands | $29.674B | 22.55 |
Terumo (TRUMY) | Japan | $28.204B | 39.83 |
Zimmer Biomet Holdings (ZBH) | United States | $21.935B | 13.81 |
Baxter (BAX) | United States | $19.749B | 13.39 |
Insulet (PODD) | United States | $16.507B | 69.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.465B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.256B | 30.67 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.864B | 33.25 |
Lantheus Holdings (LNTH) | United States | $7.251B | 17.41 |
ICU Medical (ICUI) | United States | $4.262B | 40.67 |
Haemonetics (HAE) | United States | $3.918B | 19.38 |
Neogen (NEOG) | United States | $3.612B | 37.89 |
TG Therapeutics (TGTX) | United States | $3.612B | 38.25 |
GN Store Nord (GNNDY) | Denmark | $3.576B | 21.54 |
Prestige Consumer Healthcare (PBH) | United States | $3.536B | 17.62 |
Perrigo (PRGO) | Ireland | $3.496B | 11.05 |
Envista Holdings (NVST) | United States | $3.310B | 17.66 |
QuidelOrtho (QDEL) | United States | $2.970B | 18.72 |
Agios Pharmaceuticals (AGIO) | United States | $2.734B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.220B | 37.25 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.109B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.029B | 54.07 |
Warby Parker (WRBY) | United States | $1.620B | 0.00 |
InMode (INMD) | Israel | $1.444B | 9.19 |
AdaptHealth (AHCO) | United States | $1.385B | 10.00 |
AtriCure (ATRC) | United States | $1.384B | 0.00 |
Owens & Minor (OMI) | United States | $1.213B | 9.36 |
Verano Holdings (VRNOF) | United States | $1.199B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.115B | 0.00 |
Evolus (EOLS) | United States | $1.032B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.29 |
Phibro Animal Health (PAHC) | United States | $0.895B | 18.57 |
National Vision Holdings (EYE) | United States | $0.852B | 27.10 |
Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.58 |
Quanterix (QTRX) | United States | $0.498B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.483B | 14.57 |
ZimVie (ZIMV) | United States | $0.430B | 39.97 |
Valneva SE (VALN) | France | $0.425B | 0.00 |
Jin Medical (ZJYL) | China | $0.422B | 0.00 |
Canopy Growth (CGC) | Canada | $0.397B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.386B | 0.00 |
Cerus (CERS) | United States | $0.330B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
Aurora Cannabis (ACB) | Canada | $0.314B | 0.00 |
Biote (BTMD) | United States | $0.295B | 13.62 |
Viemed Healthcare (VMD) | United States | $0.281B | 30.17 |
Zynex (ZYXI) | United States | $0.262B | 45.89 |
Sanara MedTech (SMTI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.233B | 15.45 |
Omeros (OMER) | United States | $0.227B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
MacroGenics (MGNX) | United States | $0.191B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.157B | 65.00 |
FitLife Brands (FTLF) | United States | $0.152B | 20.55 |
Brainsway (BWAY) | Israel | $0.137B | 164.20 |
TriSalus Life Sciences (TLSI) | United States | $0.122B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.117B | 0.00 |
Veru (VERU) | United States | $0.114B | 0.00 |
Fonar (FONR) | United States | $0.112B | 11.39 |
Jushi Holdings (JUSHF) | United States | $0.105B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 24.00 |
Zevia PBC (ZVIA) | United States | $0.085B | 0.00 |
InterCure (INCR) | Israel | $0.083B | 14.08 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Modular Medical (MODD) | United States | $0.077B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.068B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.44 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.89 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |